Skip to main content

and
  1. Article

    Open Access

    The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study

    Payment for oncology care is increasingly moving from fee-for-service to value-based payment (VBP). VBPs are agreements in which providers are held accountable for total cost of care (TCOC) through risk-sharin...

    **gyan Yang, Basit I. Chaudhry, Andrew T. Yue, Joshua A. Roth in Advances in Therapy (2024)